Navigation Links
Georgia Tech launches HomeLab to help companies evaluate home health technologies
Date:6/12/2012

Baby boomers have witnessed many technological innovations, and they expect technology to provide them with solutions to help maintain their independence for as long as possible. They are outfitting their homes with products to help them live healthy lifestyles, manage chronic conditions, remember to take medications and remain connected with their caregivers.

To help companies evaluate baby boomers' perceptions, use and acceptance of home health and wellness technologies, the Georgia Institute of Technology has launched HomeLab. HomeLab is a statewide network of adults 50 years of age and older recruited to evaluate the in-home usability and effectiveness of consumer products designed for the aging adult population.

HomeLab currently consists of 100 homes distributed throughout the state of Georgia; the network is expected to grow to 150 homes later this year and 550 homes by 2014.

"My wife and I are in generally good health and are interested in assisting homebound citizens by evaluating new innovations for their independent living. We want to be part of the solution for this excellent challenge," said Ivan Cottrell. Cottrell signed up to be a HomeLab participant with his wife, Judy, who was a home health nurse in Florida and witnessed many seniors struggling to stay in their own homes.

The HomeLab infrastructure lessens the burden for companies that need to find participants 50 years of age and older for extended in-home product testing. Because Georgia Tech collects detailed information about each HomeLab participant's health and home up front, individuals can be rapidly recruited for targeted short- and long-term product testing.

"HomeLab provides an efficient means for companies to limit the cost of extensive user testing that is required to bring a product to market," said Brad Fain, director of HomeLab and a principal research scientist in the Georgia Tech Research Institute (GTRI). "Evaluation of a pre-market or mature technology by Georgia Tech's HomeLab will provide a company with documented evidence for marketing, regulatory compliance and product design."

GTRI has a history of helping companies evaluate and improve the design of consumer products and currently serves as the independent product testing organization for the U.S. Arthritis Foundation, the Arthritis Society of Canada and Arthritis Australia. If a product passes GTRI's rigorous ease-of-use testing, the company that created the product can use the arthritis organization's logo in its advertisements and on its packaging.

For this work, GTRI recruits users to test a variety of consumer products -- medicine bottles, beverage containers, office supplies, medical devices, vehicles and cell phones -- in its Accessibility Evaluation Facility for at most a few hours.

With the launch of HomeLab, GTRI will expand its product testing program to include extended in-home product evaluations, which will range from one month to one year in duration and involve 25 to 125 participants who are compensated for their time. HomeLab will provide companies with product design support, early product testing, and formal usability and effectiveness evaluations.

"It is important that companies obtain consumer feedback on products as early as possible in the design process and HomeLab can facilitate an early connection with target populations to evaluate design concepts or early prototypes," noted Fain.


'/>"/>

Contact: Abby Robinson
abby@innovate.gatech.edu
404-385-3364
Georgia Institute of Technology Research News
Source:Eurekalert

Related medicine news :

1. UCLA launches first face transplantation program in western US
2. Original research papers on acute cardiovascular care: ESC launches EHJ-ACVC
3. Mayo Clinic launches whole genome breast cancer study
4. IntegraGen launches ARISk test, a genetic screening tool for autism in high-risk children
5. Kudos for 3 NJIT Enterprise Development Center high-tech companies
6. Scientists evaluate different antimicrobial metals for use in water filters
7. Study evaluates use of inhaled saline for young children with cystic fibrosis
8. Study recommends ways to evaluate end-of-life care in nursing homes
9. Noisy Wards Could Threaten Hospital Patients Health
10. Mental Health Woes Raise Odds for Prescription Painkiller Abuse
11. Most Extreme Preemies Grow Into Happy, Healthy Teens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... ... for documenting and diagramming network and data center assets and audio-video devices has ... can request new equipment shapes for free and download shapes and stencils from ...
(Date:3/29/2017)... ... 2017 , ... An inventor from Raynham, Mass., knows the ... conjunction with my braces always rubbed against the inside of my cheeks, causing ... problem." The O.B.S. was the result of his brainstorming. , This patent-pending invention ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly of synthetic DNA ... many repetitive steps and often scientists require many different versions of DNA. Therefore, ... results in a lower error rate and cost saving for reagents and consumables. ...
(Date:3/29/2017)... ... 29, 2017 , ... Hamlin Dental Group, multi-location dental office in North ... Dental lasers are safe and effective options, and can be used alone or in ... overall quality of care. , Dr. Hamid Reza of Hamlin Dental Group offers other ...
(Date:3/29/2017)... ... March 29, 2017 , ... Physicians’ Education Resource® (PER®), ... medical education conference for clinicians who manage some of the most difficult-to-treat forms ... , The program will be led by co- chairs Dr. John Marshall, chief ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... March 29, 2017  Experts in the field ... devices like  Soberlink Systems  as a model for ... published in early 2017, concluded that remote blood ... managing patient recovery." The findings of ... Addiction Medicine, detail a range of variables that ...
(Date:3/29/2017)... , March 29, 2017  Glenmark Pharmaceuticals, ... for GSP 301, an investigational fixed-dose combination of ... mcg) administered twice-daily as a nasal spray being ... These results are from a recently completed Phase ... GSP 301 combination therapy versus mometasone, olopatadine or ...
(Date:3/29/2017)... 29, 2017 Research and Markets has announced ... report to their offering. ... The global lifestyle drugs market to grow at a ... report, Global Lifestyle Drugs Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
Breaking Medicine Technology: